ClinicalTrials.gov
public full text
Public Domain
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
cervical-cancerendometrial-cancergastric-cancerhead-and-neck-squamous-cell-carcinomanon-small-cell-lung-cancerovarian-cancerpancreatic-ductal-adenocarcinomatriple-negative-breast-cancer
A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients with locally advanced or metastatic, relapsed or refractory carcinomas
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors#896777
- Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors#1231578
- UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors#891979
- NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies#808018
- Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors#1171737
Record · ID 1376701
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive